Table 2.
Univariate and multivariate analysis of prognostic parameters in 152 BC patients
| Prognostic parameters | Median overall survival (mo) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| HR (95% CI) | P‐value | HR (95% CI) | P‐value | ||
| Age (y) (>60 vs ≤60) | 40.0 vs 71.0 | 1.80 (1.01, 3.22) | .047 | 1.71 (0.92, 3.19) | .089 |
| Gender (male vs female) | 56.0 vs 34.5 | 0.95 (0.40, 2.23) | .903 | 0.93 (0.39, 2.24) | .876 |
| Tumor multiplicity (multifocal vs unifocal) | 56.0 vs 43.0 | 1.09 (0.62, 1.93) | .759 | 1.20 (0.66, 2.18) | .545 |
| Tumor size (cm) (>3 vs ≤3) | 57.5 vs 43.5 | 1.17 (0.65, 2.09) | .604 | 1.32 (0.72, 2.39) | .366 |
| pT status (T3‐T4 vs T1‐T2) | 33.0 vs 80.0 | 3.73 (1.96, 7.10) | <.001 | 2.96 (1.46, 5.99) | .003 |
| pN status (N+ vs N−) | 30.0 vs 68.5 | 1.47 (0.76, 2.85) | .256 | 1.03 (0.50, 2.15) | .929 |
| Histological grade (high vs low) | 51.0 vs 59.0 | 1.51 (0.54, 4.20) | .431 | 1.21 (0.42, 3.46) | .720 |
| KIFC1 expression (high vs low) | 33.0 vs 76.0 | 3.12 (1.71, 5.71) | <.001 | 2.50 (1.33, 4.72) | .005 |
Bold values represent P < .05.